Through the analysis of BM samples from patients with M0-M5 AML, which express high levels of MCT1, it was observed that leukemia cells prefer to localize near the bones (paratrabecular region) of the BM, where VEGF production is active [124]. This evidence concerns the gene SLC16A1 and leukemia.